Atlas Trials

Stage III Lip and Oral Cavity Cancer AJCC v8

16 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Stage III Lip and Oral Cavity Cancer AJCC v8

RecordFirmDate
Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma (NCT07156227)National Cancer Institute (NCI)2027-02-13
Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin (NCT07441681)NRG Oncology2026-07-31
Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer (NCT06980038)National Cancer Institute (NCI)2026-05-27
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer (NCT07195734)National Cancer Institute (NCI)2026-04-24
Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the Treatment of Oral Cavity Squamous Cell Carcinoma, PRECEDENT Trial (NCT07121595)University of Michigan Rogel Cancer Center2025-07-17
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer (NCT06532279)NRG Oncology2025-06-23
A Fluorescent Tumor Marking Agent, Tozuleristide, for Imaging Oral Cavity Squamous Cell Cancer and High-Grade Oral Cavity Dysplasia During Surgery (NCT05316688)University of Washington2024-04-17
Testing the Addition of an Investigational Drug, Xevinapant, to Usual Radiation Therapy Plus Cisplatin/Carboplatin for Patients With Head and Neck Cancer (NCT06084845)ECOG-ACRIN Cancer Research Group2024-04-12
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study (NCT05136196)National Cancer Institute (NCI)2022-12-06
A Pneumatic Compression Device for the Treatment of Lymphedema in Patients With Stage II-IV Head and Neck Cancer After Chemoradiation (NCT05512767)Mayo Clinic2022-12-01
Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer (NCT05172245)National Cancer Institute (NCI)2022-09-19
Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer (NCT04576091)National Cancer Institute (NCI)2022-07-06
Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take Cisplatin (NCT04533750)National Cancer Institute (NCI)2021-12-20
Sodium Thiosulfate in Preventing Ototoxicity for Squamous Cell Cancer Patients Undergoing Chemoradiation With Cisplatin (NCT04541355)Hyunseok Kang, MD2020-10-14
Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin (NCT03258554)National Cancer Institute (NCI)2018-04-03
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery (NCT02734537)ECOG-ACRIN Cancer Research Group2016-11-23

Track Stage III Lip and Oral Cavity Cancer AJCC v8 automatically

Every clearance here is in the API, with alerts when new ones post.